FAH and psoriasis: On the contrary, vascular endothelial growth factor receptor 3 (VGFR3) [FC = 5.1; p = 0.0008], phosphatidylinositol-glycan-specific phospholipase (PHLD) [FC = 1.7; p = 0.002], the complement C1QB chain [FC = 1.3; p = 0.03], or fumarylacetoacetase (FAAA) [FC = 17; p = 0.03] were upregulated in psoriasis donors.